telmisartan has been researched along with Uterine Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Isobe, A; Kimura, T; Minekawa, R; Miyake, A; Nishimoto, F; Oskamoto, Y; Sakata, M; Takeda, T; Walker, CL; Yamamoto, T | 1 |
1 other study(ies) available for telmisartan and Uterine Neoplasms
| Article | Year |
|---|---|
Dual repressive effect of angiotensin II-type 1 receptor blocker telmisartan on angiotensin II-induced and estradiol-induced uterine leiomyoma cell proliferation.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cell Line, Tumor; Cell Proliferation; Estradiol; Female; Leiomyoma; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction; Telmisartan; Uterine Neoplasms | 2008 |